Finally, we noted in the CY 2026 OPPS/ASC proposed rule that the intent of transitional device pass-through payment, as implemented at 419.66, is to facilitate access for beneficiaries to the advantages of new and truly innovative devices by allowing for adequate payment for these new devices while the necessary cost data is collected to incorporate the costs for these devices into the procedure APC rate (66 FR 55861)
Poor cognitive ageing: vulnerabilities, mechanisms and the impact of nutritional interventions
The effect of secukinumab on moderate-to-severe scalp psoriasis: results of a 24-week, randomized, double-blind, placebo-controlled phase 3b study
Not approved by the TGA for therapeutic use
When we design our formulations at Cymbiotika, we focus on overcoming these digestive barriers
De Freitas GR, Ferraz GAM, Gehlen M, Skare TL